Literature DB >> 3944261

Differential binding of immunoglobulin A and immunoglobulin G1 immune complexes to primate erythrocytes in vivo. Immunoglobulin A immune complexes bind less well to erythrocytes and are preferentially deposited in glomeruli.

F J Waxman, L A Hebert, F G Cosio, W L Smead, M E VanAman, J M Taguiam, D J Birmingham.   

Abstract

Primate erythrocytes appear to play a role in the clearance of potentially pathogenic immune complexes (IC) from the circulation. This study was undertaken to compare the clearance from the circulation and tissue uptake of two monoclonal IC probes: one of which, IgG1-IC, was bound well by erythrocytes, the other of which, IgA-IC, was bound relatively poorly by erythrocytes. The IC probes were labeled with different iodine isotopes and infused either concomitantly or sequentially into the arterial circulation. The results indicate that, compared with IgG1-IC, IgA-IC bind less well to primate erythrocytes, are cleared from the circulation more quickly despite their smaller size, and show increased uptake in kidney and lung but decreased uptake in liver and spleen. Evidence is presented which suggests that this pattern of clearance from the circulation and systemic uptake of IgA-IC is the result of decreased binding of IgA-IC to circulating erythrocytes. These findings support the hypothesis that the primate erythrocyte-IC clearing mechanism may be critically important for the safe removal of IC from the circulation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3944261      PMCID: PMC423312          DOI: 10.1172/JCI112306

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  26 in total

1.  Some hemodynamic determinants of immune complex trapping by the kidney.

Authors:  L A Hebert; C L Allhiser; S M Koethe
Journal:  Kidney Int       Date:  1978-11       Impact factor: 10.612

2.  Nephritogenicity and differential distribution of glomerular immune complexes related to immunogen charge.

Authors:  G R Gallo; T Caulin-Glaser; S N Emancipator; M E Lamm
Journal:  Lab Invest       Date:  1983-03       Impact factor: 5.662

3.  Characterization of mouse monoclonal antibodies specific for Friend murine leukemia virus-induced erythroleukemia cells: friend-specific and FMR-specific antigens.

Authors:  B Chesebro; K Wehrly; M Cloyd; W Britt; J Portis; J Collins; J Nishio
Journal:  Virology       Date:  1981-07-15       Impact factor: 3.616

4.  Complement depletion accelerates the clearance of immune complexes from the circulation of primates.

Authors:  F J Waxman; L A Hebert; J B Cornacoff; M E VanAman; W L Smead; E H Kraut; D J Birmingham; J M Taguiam
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

5.  Studies on passive serum sickness. II. Factors determining the localization of antigen-antibody complexes in the murine renal glomerulus.

Authors:  A Koyama; Y Niwa; H Shigematsu; M Taniguchi; T Tada
Journal:  Lab Invest       Date:  1978-03       Impact factor: 5.662

6.  Relations between surface charge and in vitro lysis of red blood cells in paroxysmal nocturnal haemoglobinuria.

Authors:  L L Hause; S M Koethe; D J Rothwell; J V Straumfjord
Journal:  Scand J Haematol       Date:  1978-02

7.  DNA/anti-DNA complexes: correlation of size and complement fixation.

Authors:  S J Waller; R P Taylor; E L Wright; K W Morley; M Johns
Journal:  Arthritis Rheum       Date:  1981-05

8.  Passive immune complex glomerulonephritis in mice: models for various lesions found in human disease. I. High avidity complexes and mesangiopathic glomerulonephritis.

Authors:  F G Germuth; E Rodriguez; C A Lorelle; E I Trump; L Milano; O Wise
Journal:  Lab Invest       Date:  1979-10       Impact factor: 5.662

9.  Passive immune complex glomerulonephritis in mice: models for various lesions found in human disease. II. Low avidity complexes and diffuse proliferative glomerulonephritis with subepithelial deposits.

Authors:  F G Germuth; E Rodriguez; C A Lorelle; E I Trump; L L Milano; O Wise
Journal:  Lab Invest       Date:  1979-10       Impact factor: 5.662

10.  Induction of membranous nephropathy in rabbits by administration of an exogenous cationic antigen.

Authors:  W A Border; H J Ward; E S Kamil; A H Cohen
Journal:  J Clin Invest       Date:  1982-02       Impact factor: 14.808

View more
  19 in total

1.  Immunoglobulin isotype composition of circulating and intra-articular immune complexes in patients with inflammatory joint disease.

Authors:  A D Crockard; J M Thompson; M B Finch; T A McNeill; A L Bell; S D Roberts
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

2.  Consumption of erythrocyte CR1 (CD35) is associated with protection against systemic lupus erythematosus renal flare.

Authors:  D J Birmingham; K F Gavit; S M McCarty; C Y Yu; B H Rovin; H N Nagaraja; L A Hebert
Journal:  Clin Exp Immunol       Date:  2006-02       Impact factor: 4.330

3.  Immune adherence of nascent hepatitis B surface antigen-antibody complexes in vivo in humans.

Authors:  N Madi; J P Paccaud; G Steiger; J A Schifferli
Journal:  Clin Exp Immunol       Date:  1989-11       Impact factor: 4.330

4.  Elimination of soluble 123I-labelled aggregates of human immunoglobulin G in humans; the effect of splenectomy.

Authors:  C Halma; M R Daha; R van Furth; J A Camps; J H Evers-Schouten; E K Pauwels; S Lobatto; L A Van Es
Journal:  Clin Exp Immunol       Date:  1989-07       Impact factor: 4.330

Review 5.  Complement activation and complement receptors in systemic lupus erythematosus.

Authors:  J P Atkinson
Journal:  Springer Semin Immunopathol       Date:  1986

6.  A lysine-binding protein in SLE sera inhibits the binding of immune complexes to normal erythrocyte CR1 (complement receptor type 1).

Authors:  Y C Ng; D K Peters; S A Cederholm-Williams; M J Walport
Journal:  Clin Exp Immunol       Date:  1987-07       Impact factor: 4.330

7.  A transgenic mouse model for studying the clearance of blood-borne pathogens via human complement receptor 1 (CR1).

Authors:  A Repik; S E Pincus; I Ghiran; A Nicholson-Weller; D R Asher; A M Cerny; L S Casey; S M Jones; S N Jones; N Mohamed; L B Klickstein; G Spitalny; R W Finberg
Journal:  Clin Exp Immunol       Date:  2005-05       Impact factor: 4.330

8.  Role of fibronectin on the clearance and tissue uptake of antigen and immune complexes in rats.

Authors:  F G Cosio; A P Bakaletz
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

9.  Complement-mediated inhibition of immune precipitation in rheumatoid vasculitis.

Authors:  M M O'Sullivan; N Amos; A Bedwell; B D Williams
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

10.  Plasma factors influencing PGI2-like activity in patients with IgA nephropathy and Henoch-Schönlein purpura.

Authors:  S Túri; J Nagy; I Haszon; Z Havass; M Németh; C Bereczki
Journal:  Pediatr Nephrol       Date:  1989-01       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.